CRISPR Therapeutics AG (CRSP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

43.85

0.23%

After-hours Dec 13, 2024, 07:08 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14
Revenue	371.21M	436.00K	913.08M	543.00K	289.59M	3.12M	41.00M	5.16M	247.00K	-
Cost of Revenue	130.25M	110.25M	17.95M	269.41M	179.36M	113.77M	69.80M	42.24M	12.57M	1.51M
Gross Profit	240.96M	-109.81M	895.13M	-268.86M	110.23M	-110.65M	-28.80M	-37.07M	-12.33M	-1.51M
Operating Income	-222.54M	-673.16M	373.53M	-354.44M	46.74M	-158.94M	-64.65M	-68.13M	-25.73M	-6.63M
Interest Income	-	-	-	-	10.03M	-	-	-	-	-
Pretax Income	-150.72M	-650.50M	379.53M	-348.06M	67.31M	-164.43M	-66.61M	-22.72M	-25.82M	-6.86M
Net Income	-153.61M	-650.17M	377.66M	-348.87M	66.86M	-164.98M	-68.36M	-23.20M	-25.83M	-6.80M
Selling & General & Admin	76.16M	102.46M	102.80M	88.21M	63.49M	48.29M	35.84M	31.06M	13.40M	5.11M
Research & Development	387.33M	461.64M	438.63M	266.95M	179.36M	113.77M	69.80M	42.24M	12.57M	1.51M
Other Expenses	-	-762.00K	-1.88M	-176.00K	20.57M	-5.49M	-197.00K	78.51M	16.00K	-236.00K
Operating Expenses	463.49M	563.35M	539.55M	354.98M	242.85M	162.07M	105.64M	73.29M	25.98M	6.63M
Interest Expense	-	-	-	-	-	-	-	8.05M	108.00K	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	593.74M	673.60M	539.55M	354.98M	242.85M	162.07M	105.64M	73.29M	25.98M	6.63M
Income Tax	2.89M	-325.00K	1.87M	809.00K	448.00K	553.00K	1.75M	484.00K	7.00K	-63.00K
Shares Outstanding (Basic)	79.22M	77.75M	75.95M	65.95M	54.39M	47.96M	39.97M	12.26M	29.30M	29.30M
Shares Outstanding (Diluted)	79.22M	77.75M	80.39M	65.95M	56.93M	47.96M	40.06M	12.26M	29.30M	29.30M
EPS (Basic)	-1.94	-8.36	4.97	-5.29	1.23	-3.44	-1.71	-1.89	-0.88	-0.23
EPS (Diluted)	-1.94	-8.36	4.70	-5.29	1.17	-3.44	-1.71	-1.89	-0.88	-0.23
EBITDA	-202.70M	-648.99M	391.48M	-345.25M	51.47M	-155.42M	-61.62M	-13.67M	-25.59M	-6.59M
Depreciation & Amortization	19.84M	24.17M	17.95M	9.18M	4.72M	3.52M	3.02M	1.00M	127.00K	38.00K